# Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine

> **NCT07563023** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 6 (estimated)

## Conditions studied

- HIV Associated Lymphoma

## Interventions

- **BIOLOGICAL:** EBV mRNA vaccine

## Key facts

- **NCT ID:** NCT07563023
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07563023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07563023, "Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07563023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*